Challenges and Solutions for ATMP Development and Commercialization
Many ATMPs are under development worldwide. Yet there are still significant challenges that complicate the process of delivering an ATMP to the patient. Some challenges require a coordinated, international approach. Other challenges can be tackled by yourself, but requires an early anticipation and a good planning. In this topic, Ingrid Maes discusses the different challenges, both for ATMPs in general and during the product life cycle. She then zooms in on the importance of collaborations, both multi-disciplinary and with different stakeholders, to find solutions to these challenges.
The Speaker
Ingrid Maes
Ingrid Maes is co-Founder and Managing Director at Inovigate, based in Antwerp (B) and Basel (CH). Ingrid has 30+ years of experience in the life science sector, in management consulting, in international leadership roles and in international companies (PwC, Siemens and Alf-Laval). She is an expert in market access with a focus on sector insight and foresight, market analysis, business planning and strategy formulation. Ingrid has a Master in Engineering Sciences – Chemistry & Biotechnology from the University of Brussels.
The Company
Inovigate
Inovigate is an independent strategy and management consulting company operating in the European Life Science and Healthcare industry, specialised in helping clients to innovate and navigate through an increasingly complex health ecosystem.